Treatment with rituximab in idiopathic membranous nephropathy

BACKGROUND: Rituximab represents a valid therapeutic option to induce remission in patients with primary glomerulonephritis. Despite several studies proving its efficacy in improving outcomes in patients with membranous nephropathy (MN), its role in therapeutic protocols is not yet defined. METHODS:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Kidney J
Autores principales: Fiorentino, Marco, Tondolo, Francesco, Bruno, Francesca, Infante, Barbara, Grandaliano, Giuseppe, Gesualdo, Loreto, Manno, Carlo
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Glomerulopathies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5162414/
https://ncbi.nlm.nih.gov/pubmed/27994855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw091
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares